Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial | NCT01418300 | Trialant
Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial
ClinicalTrials.gov ID
NCT01418300
Lead Sponsor
Jun-Won ChungINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
159Actual
Last Update Posted
Apr 28, 2015Estimated
Start Date
Aug 2010
Primary Completion Date
Aug 2011Actual
Completion Date
Dec 2011Actual
Brief Summary
The purpose of this study is to improve first line Helicobacter pylori eradication rate and to compare the sequential versus conventional triple therapy.
Helicobacter Infected Patients
sequential versus triple
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
peptic ulcer diseae
two test positive rapid urease test, culture, histology